Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2071250055) titled 'A Clinical Trial of KDT-3594 to Evaluate the Drug-Drug Interaction with Itraconazole' on Aug. 1.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), uncontrolled control, crossover assignment, other
Primary Sponsor: Shimizu Yoshitaka
Condition:
Parkinson disease
Intervention:
1) Period I
KDT-3594 will be administered as a single oral dose to the participants about one hour after the end of breakfast on Day 1.
2) Period II
- Day 1-3: Itraconazole will be administered orally to the participants once a day immediately after breakfast.
- Day 4: Itraconazole will be administere...